CORCEPT THERAPEUTICS INC Debt Securities Available For Sale Excluding Accrued Interest
CORCEPT THERAPEUTICS INC (CORT) had Debt Securities Available For Sale Excluding Accrued Interest of $490.93 million as of 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-04-30
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $490.93M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $511.69M.
- 2025-03-31: Debt Securities Available For Sale Excluding Accrued Interest $550.65M.
- 2024-12-31: Debt Securities Available For Sale Excluding Accrued Interest $573.94M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-03-31 | $490.93M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $511.69M 10-Q · filed 2026-04-30 |
| 2025-03-31 | $550.65M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $573.94M 10-Q · filed 2025-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |